Publications

2018

Hwang TJ, Tomasi PA, Bourgeois FT. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: a cohort study. PLOS Medicine 2018;15(3):e1002520. PubMed

Hwang TJ, Tomasi PA, Saint-Raymond A, Bourgeois FT. Availability of paediatric information in European Medicines Agency approvals. Lancet Child and Adolescent Health 2018;2(5):e9. PubMed

Hudgins JD, Bacho MA, Olsen KL, Bourgeois FT. Pediatric drug information available at the time of new drug approvals: A cross-sectional analysis. Pharmacoepidemiology and Drug Safety 2018;27(2):161-167. PubMed

Bourgeois FT, Hwang TJ. Improving the study of new medicines for children with rare diseases. JAMA Pediatrics 2018;172(1):7-9. PubMed

2016-7

Bourgeois FT, Hwang TJ. The Pediatric Research Equity Act moves into adolescence. JAMA 2017;317(3):259-260. PubMed

Pica N, Bourgeois F. Discontinuation and nonpublication of randomized clinical trials conducted in children. Pediatrics 2016;138(3):e20160223. PubMed

Lebowitz MB, Olson KL, Burns M, Harper MB, Bourgeois F. Drug-drug interactions among hospitalized children receiving chronic antiepileptic drug therapy. Hospital Pediatrics 2016;6(5):282-289. PubMed

2014-5

Bourgeois FT, Olson KL, Poduri A, Mandl KD. Comparison of drug utilization patterns in observational data: antiepileptic drugs in pediatric patients. Paediatric Drugs 2015;17(5):401-410. PubMed

Hwang TJ, Kesselheim AS, Bourgeois FT. Postmarketing trials and pediatric device approvals. Pediatrics 2014;133(5):e1197-1202. PubMed

Hwang TJ, Bourgeois FT. New regulatory paradigms for innovative drugs to treat pediatric diseases. JAMA Pediatrics. 2014;168(10):879-880. PubMed

Bourgeois F, Olson K, Ioannidis J, Mandl K. Association between pediatric clinical trials and global burden of disease. Pediatrics 2014;133(1):78-87. PubMed

Tay KY, Ewald M, Bourgeois F. Use of QT-prolonging medications in US emergency departments, 1995-2009 Pharmacoepidemiology and Drug Safety 2014;23(1):9-17. PubMed

Bourgeois FT, Kim JM, Mandl KD. Premarket safety and efficacy studies for ADHD medications in children. PLoS One. 2014;9(7):e102249. PubMed